Communicators: Michael Bradley
Q&A with Michael Bradley, Senior Account Director at Langland
PharmaTimes Magazine
PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What's more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
View more from the latest edition
Patient Files: XLH
PharmaTimes talks to Emily McKechnie about the rare genetic disorder XLH and the Shine a Light on XLH campaign
Nature’s pharmacy
An in-depth look at medical cannabis from Professor Trevor Jones
Shaping the future
EB McLindon considers whether 2020 will accelerate transformation in approach for longer term resilience in clinical research
Cold chain in 2021
Dave Williams' predictions for COVID-19's continued influence on the industry
News travels fast
Communication between pharma, patients and wider healthcare has helped to create a solid foundation upon which the general public understands disease and, crucially, trusts emerging therapies. Now that vaccines promise a ‘way out’ of the COVID-19 impasse, pharma’s direction has never (ever) been more important
Beyond the finish line
How can pharma help drive COVID-19 vaccination adherence?
The UK-EU trade deal: now for the hard part
Paul McGrade's take on what the pharma industry should focus on now
